Abstract:RNA-binding proteins (RBPs) control mRNA processing, stability, transport, editing, and translation. We recently conducted transcriptome analyses comparing normal (i. e., healthy) cervical tissue samples with human papillomavirus (HPV)-positive cervical cancer tissue samples and identified 614 differentially expressed protein-coding transcripts which are enriched in cancer-related pathways and consist of 95 known RBPs. We verified the altered expression of 26 genes with a cohort of 72 cervical samples, including 24 normal cervical samples, 25 cervical intraepithelial neoplasia grade 2 (CIN2) and CIN3 samples, and 23 cervical cancer tissue samples. LY6K (lymphocyte antigen 6 complex locus K), FAM83A (family member with sequence similarity 83), CELSR3, ASF1B, IQGAP3, SEMA3F, CLDN10, MSX1, CXCL5, ASRGL1, ELAVL2, GRB7, KHSRP, NOVA1, PTBP1, and RNASEH2A were identified as novel candidate genes associated with cervical lesion progression and carcinogenesis. HPV16 or HPV18 infection was found to alter the expression of 8 RBP genes (CDKN2A, ELAVL2, GRB7, HSPB1, KHSRP, NOVA1, PTBP1, and RNASEH2A) in human vaginal and foreskin keratinocytes. Both viral E6 and E7 decreased NOVA1 expression, but only E7 increased the expression of RNASEH2A in an E2F1-dependent manner. Proliferating cell nuclear antigen (PCNA) directs RNASEH2 activity with respect to DNA replication by removing the RNA primers to promote Okazaki fragment maturation, and two factors are closely associated with neoplasia progression. Therefore, we predict that the induction of expression of RNASEH2A via viral E7 and E2F1 may promote DNA replication and cancer cell proliferation. IMPORTANCE High-risk HPV infections lead to development of cervical cancer. This study identified the differential expression of 16 novel genes (LY6K, FAM83A, CELSR3, ASF1B, IQGAP3, SEMA3F, CLDN10, MSX1, CXCL5, ASRGL1, ELAVL2, GRB7, KHSRP, NOVA1, PTBP1, and RNASEH2A) in HPV-infected cervical tissue samples and keratinocytes. Eight of these genes (CDKN2A, ELAVL2, GRB7, HSPB1, KHSRP, NOVA1, PTBP1, and RNASEH2A) encode RNA-binding proteins. Further studies indicated that both HPV16 and HPV18 infections lead to the aberrant expression of selected RBPencoding genes. We found that viral E6 and E7 decrease NOVA1 expression but that E7 increases RNASEH2A expression via E2F1. The altered expression of these genes may be utilized as biomarkers for high-risk (HR)-HPV carcinogenesis and progression.

Expression Pattern and Subcellular Localization of Human Papillomavirus Minor Capsid Protein L2

Immunopathology and Infectious Diseases Expression Pattern and Subcellular Localization of Human Papillomavirus Minor Capsid Protein L 2

Cell surface-binding motifs of L2 that facilitate papillomavirus infection.

Significance of SHP-1 and SHP-2 Expression in Human Papillomavirus Infected Condyloma acuminatum and Cervical Cancer

Critical Residues Involved in the Coassembly of L1 and L2 Capsid Proteins of Human Papillomavirus 16

Crystal Structures of Plk1 Polo-Box Domain Bound to the Human Papillomavirus Minor Capsid Protein L2-Derived Peptide

Hpv-2 Isolates from Patients with Huge Verrucae Vulgaris Possess Stronger Promoter Activities

Prokaryotic Expression and Purification of Minor Capsid Protein L2 Derived from Human Papillomavirus 58 and Preparation of Monoclonal Antibody

Genome-Wide Profiling of Cervical RNA-Binding Proteins Identifies Human Papillomavirus Regulation of RNASEH2A Expression by Viral E7 and E2F1

The C-Terminal Arm of the Human Papillomavirus Major Capsid Protein is Immunogenic and Involved in Virus-Host Interaction

A Point Mutation in the DNA-binding Domain of HPV-2 E2 Protein Increases Its DNA-binding Capacity and Reverses Its Transcriptional Regulatory Activity on the Viral Early Promoter.

Screening and identification of B cell epitope within the major capsid protein L1 of HPV 52, using monoclonal antibodies

Comprehensive Evaluation of the Antigenic Impact of Intra-Genotypic Human Papillomavirus Variant Diversity on Recognition by Neutralizing Monoclonal Antibodies Raised Against Lineage a L1 Virus Like Particles

Mapping the B Cell Epitopes Within the Major Capsid Protein L1 of Human Papillomavirus Type 16.

A Ran-binding protein facilitates nuclear import of human papillomavirus type 16

Translocation of the papillomavirus L2/vDNA complex across the limiting membrane requires the onset of mitosis

Definition of linear antigenic regions of the HPV16 L1 capsid protein using synthetic virion-like particles

Identification of Broad-Genotype HPV L2 Neutralization Site for Pan-HPV Vaccine Development by a Cross-Neutralizing Antibody

Clinicopathological Implications of Human Papilloma Virus (HPV) L1 Capsid Protein Immunoreactivity in HPV16-Positive Cervical Cytology

Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer.

Expression of HPV L1 capsid protein in cervical specimens with HPV infection